What Are the Bilirubin Levels for Breast Milk Jaundice?

Breast milk jaundice typically pushes a newborn’s total serum bilirubin (TSB) into the range of 12 to 20 mg/dL, with levels occasionally climbing higher in babies who carry certain genetic variants. Unlike the more common early jaundice linked to feeding difficulties, true breast milk jaundice shows up later and lingers longer, which understandably alarms parents even though the condition is almost always harmless. The numbers that matter depend on when the yellowing appears, how quickly bilirubin is rising, and whether the baby has any additional risk factors.

Breast Milk Jaundice Versus Breastfeeding Jaundice

Pediatricians recognize two distinct forms of jaundice in breastfed babies, and mixing them up is one of the most common sources of confusion for new parents. The first, called breastfeeding jaundice, appears in the first few days of life and is essentially a calorie and hydration problem. The baby is not getting enough milk yet, stool output is low, and bilirubin that would normally leave through the gut gets reabsorbed into the bloodstream. In this early form, bilirubin usually peaks around days five or six and can reach 18 to 20 mg/dL if feeding remains inadequate.¹

The second form, true breast milk jaundice, is a different animal. It shows up later, often after the first week of life, and can persist for weeks or even a couple of months. The cause is not insufficient feeding but something in the milk itself that slows the baby’s ability to clear bilirubin.² Levels in breast milk jaundice generally hover in the moderate range but can occasionally push well above 20 mg/dL in susceptible infants. The distinction matters because the fix for breastfeeding jaundice is better and more frequent feeding, while true breast milk jaundice usually resolves on its own with continued nursing.

Typical Bilirubin Levels and When They Peak

A pooled analysis of twelve studies found that moderate jaundice, defined as a bilirubin level of 12 mg/dL or higher, occurred in roughly 13 percent of breastfed newborns compared with about 4 percent of formula-fed newborns. Severe jaundice at 15 mg/dL or above was rarer but still more than five times as common in the breastfed group.³ Those numbers represent neonatal jaundice broadly in breastfed infants, not exclusively the late-onset breast milk jaundice syndrome, but they capture the overall landscape parents and clinicians face.

In classic breast milk jaundice, bilirubin tends to rise after the first week, often peaking somewhere between days 10 and 21 of life. For many babies, levels sit in the 12 to 17 mg/dL range and then gradually drift downward over the next several weeks. A smaller subset reaches the upper teens or low twenties. In one study of 170 infants diagnosed with breast milk jaundice who carried a particular genetic variant, the average bilirubin was about 22 mg/dL.⁴ That is high enough to trigger phototherapy in most clinical guidelines, so genetics can meaningfully shift where a baby’s bilirubin lands.

Why Breast Milk Causes Higher Bilirubin

The short version: certain substances in human milk increase the recycling of bilirubin through the baby’s gut and back into the bloodstream. One of the best-studied culprits is an enzyme called beta-glucuronidase. The baby’s liver packages bilirubin into a water-soluble form so it can leave through stool. Beta-glucuronidase in breast milk reverses that packaging, freeing bilirubin back into a form the intestine reabsorbs. Studies have found that beta-glucuronidase activity in formula is negligible, while in human milk it is substantial, and that babies’ bilirubin levels track with the amount of this enzyme in their mother’s milk.⁵ When researchers temporarily switched hyperbilirubinemic babies from breast milk to formula, the enzyme activity in stool dropped sharply and bilirubin fell in parallel.

Fatty acids in breast milk also play a role. Oleic acid, linoleic acid, and DHA all strongly inhibit the liver enzyme responsible for conjugating bilirubin, which is the critical step that makes bilirubin excretable.⁶ So the same fatty acids that are nutritionally important for the baby’s developing brain simultaneously slow down bilirubin clearance. This is one reason breast milk jaundice is considered a normal, even expected, consequence of human lactation rather than a disease state.

Newer research suggests the baby’s gut microbiome mediates some of this as well. Certain Bifidobacterium species that flourish in breastfed infants appear to regulate fatty acid metabolism in the gut in ways that can actually reduce bilirubin reabsorption, providing a partial counterbalance to the other milk components that raise it.⁷ The interplay between milk composition, gut bacteria, and bilirubin handling is still being mapped out, but it helps explain why some breastfed babies develop clinically significant jaundice and others do not.

The Genetic Piece

Not every breastfed baby gets jaundice, and one of the biggest reasons is genetic variation in how efficiently the baby’s liver processes bilirubin. The enzyme that conjugates bilirubin in the liver is coded by a gene called UGT1A1. Mutations in this gene, the same ones found in adults with Gilbert syndrome, are now recognized as an underlying cause of prolonged breast milk jaundice.⁸ Something in the milk triggers jaundice, but the baby’s ability to handle that trigger depends heavily on which version of UGT1A1 they inherited.

In a study of 170 infants with breast milk jaundice, over half were homozygous for one particular UGT1A1 variant, and those babies had significantly higher bilirubin than babies with other genotypes.⁴ This is a useful finding because it reframes the condition: breast milk jaundice is not purely about the milk. It is about the interaction between what is in the milk and how well a particular baby’s liver can compensate. Two siblings fed by the same mother can have very different jaundice trajectories.

Ethnic and Racial Variation in Risk

Neonatal jaundice is more common and tends to be more severe in certain populations. A large study found that infants of full Asian parentage were about 37 percent more likely to be diagnosed with jaundice than white infants. Among specific groups, Japanese infants had roughly double the risk, and Filipino infants had about a third higher risk. The risk of severe jaundice was about 70 percent greater in babies with two Asian parents.⁹ These differences persisted even after adjusting for maternal age, birth weight, gestational age, and other factors, pointing to a biological rather than behavioral explanation.

Similar patterns have been documented in Native American populations. Alaskan Eskimo newborns showed bilirubin levels comparable to those seen in other Indigenous and East Asian groups and higher than those seen in white and Black newborns. Breast milk from these mothers showed a pronounced ability to inhibit the liver enzyme that clears bilirubin, though the researchers noted this only partly accounted for the difference between breastfed and bottle-fed infants in this group.¹⁰ The upshot is that if your family background includes East Asian, Southeast Asian, or Indigenous ancestry, your baby may need a closer eye on bilirubin levels during the newborn period, and a slightly higher level may be expected without indicating anything more serious than the usual breast milk jaundice.

When Prolonged Jaundice Needs a Closer Look

Jaundice lasting past two weeks of age is common and is usually benign breast milk jaundice. But it overlaps with a small group of conditions that are not benign and need to be caught early. The most important one is biliary atresia, a rare condition where the bile ducts outside the liver are blocked or absent. Distinguishing biliary atresia from breast milk jaundice early on dramatically affects outcomes, because surgery works much better when performed in the first weeks of life.¹¹

The key distinction comes down to what type of bilirubin is elevated. Breast milk jaundice causes a rise in unconjugated (indirect) bilirubin, the form that has not yet been processed by the liver. Conditions like biliary atresia cause a rise in conjugated (direct) bilirubin, the processed form that should be flowing out through bile. Any baby with prolonged jaundice should have a fractionated bilirubin test to check whether the conjugated portion is elevated, because elevated conjugated bilirubin is a red flag for liver disease.¹² If your baby is still visibly yellow at three or four weeks, the pediatrician should be checking this. If the stool is pale or chalky rather than the expected yellow-green, bring it up immediately.

How Bilirubin Is Measured

Most parents first encounter bilirubin testing through a transcutaneous device, a handheld meter pressed against the baby’s skin that estimates bilirubin based on skin color. These devices are widely used for screening and generally provide a reasonable estimate. In large studies, the average difference between the skin reading and a blood draw was small, roughly 1 mg/dL, though the direction of the error and its size vary by the baby’s skin tone, the specific device used, and the baby’s age in hours.¹³ The skin reading tends to overestimate the true blood level by a small amount in most newborns, which is a reasonable direction for a screening test to err.¹⁴

After phototherapy, though, the skin reading becomes unreliable. Phototherapy bleaches the bilirubin in the skin without immediately lowering what is in the blood, so the skin meter underestimates the true level. One study found that the meter systematically read lower than blood levels after phototherapy, even on skin that had been covered during treatment.¹⁵ If your baby has had phototherapy and needs follow-up testing, expect a blood draw rather than a skin check.

Treatment Thresholds and What Happens in Practice

Deciding when to treat depends on the baby’s age in hours, gestational age, and whether any additional risk factors for bilirubin toxicity are present. The American Academy of Pediatrics updated its phototherapy guidelines in 2022, providing hour-by-hour threshold nomograms rather than a single cutoff number.¹⁶ For a healthy full-term baby at 72 hours of age, for example, phototherapy is typically recommended when TSB reaches roughly 18 to 20 mg/dL, while a baby with risk factors has a lower threshold. The thresholds rise with age, reflecting the decreasing vulnerability of the older newborn brain.

For most babies with breast milk jaundice, phototherapy brings levels down quickly, and the question then becomes whether to interrupt breastfeeding. Older advice often recommended temporarily switching to formula for 24 to 48 hours. A study comparing that approach to continuing breastfeeding during phototherapy found no significant difference in how quickly bilirubin fell below 13 mg/dL. However, the babies who were temporarily weaned experienced more nipple confusion and their mothers had more breast engorgement.¹⁷ The trend in current practice is to continue breastfeeding alongside phototherapy rather than interrupting it, unless bilirubin is at a dangerous level and not responding.

In the early days, before breast milk jaundice has fully declared itself, supplemental formula feeding can reduce peak bilirubin. Research on newborns who received early formula supplementation alongside breastfeeding showed lower bilirubin levels at 72 hours compared with exclusively breastfed controls, with greater effect seen in babies who got supplementation on consecutive days.¹⁸ This is most relevant for preventing early breastfeeding jaundice rather than the later breast milk jaundice syndrome, but it illustrates how feeding volume in the first days shapes the bilirubin trajectory.

Is Breast Milk Jaundice Dangerous?

For the vast majority of babies, no. Studies following infants with breast milk jaundice into childhood have found no developmental problems or hearing deficits, which has led pediatric groups to encourage continued breastfeeding in healthy jaundiced infants.¹⁹ The condition resolves on its own, and the bilirubin levels involved almost never reach the range that threatens the brain.

The exception, and the reason clinicians still watch closely, is that on very rare occasions, breastfed babies without any identifiable blood disorder have developed extreme bilirubin levels and kernicterus, a form of brain damage caused by bilirubin toxicity.²⁰ Nearly all cases of kernicterus reported in recent decades have occurred in fully or partially breastfed newborns, not because breastfeeding is inherently dangerous but because this is the population where bilirubin is most likely to climb unchecked if monitoring lapses.²¹ The lesson is not to avoid breastfeeding but to make sure bilirubin is being tracked in the first couple of weeks, especially if the baby seems excessively sleepy, feeds poorly, or the yellowing deepens rather than fading.

Among babies who did develop very high bilirubin, follow-up between three months and two years showed resolution of clinical signs in nearly all of them, though one infant had residual hearing impairment and another had developmental issues that appeared unrelated to classic kernicterus on imaging.²² The outcomes data are reassuring overall, but they underscore why monitoring matters: catching a rapid rise early keeps babies out of the danger zone.

The Emotional Toll on Parents

Numbers and thresholds aside, breast milk jaundice has a real psychological dimension. Surveys of new parents find that roughly two thirds worry when their baby develops jaundice. About a quarter believe that stopping breastfeeding is an appropriate response, and nearly a third view breastfeeding itself as a risk factor for the condition.²³ The syndrome has long been recognized as a source of maternal anxiety and guilt, sometimes prompting families to stop nursing prematurely.²⁴

If you are in this situation, the single most useful piece of information is the fractionated bilirubin result. When the unconjugated bilirubin is the elevated portion, the baby is thriving, gaining weight, producing wet and dirty diapers, and the level is not rocketing up, breast milk jaundice is overwhelmingly the answer. You do not need to stop breastfeeding. If a clinician tells you to stop without checking conjugated bilirubin first, or without plotting the total level against the phototherapy threshold for your baby’s age, it is reasonable to ask for those steps before making a decision that can disrupt the nursing relationship.

Bilirubin as More Than a Waste Product

There is growing scientific interest in the idea that mild jaundice in the newborn period may actually serve a protective function. Bilirubin is a potent antioxidant, and some researchers have proposed that the transient rise in bilirubin seen in virtually all newborns helps buffer oxidative stress during the transition from the low-oxygen womb to the high-oxygen outside world.²⁵ The same paper notes a correlation between moderately elevated bilirubin and increased fitness in elite athletes, suggesting the molecule has biological value beyond waste disposal. None of this means high bilirubin is good for a newborn, but it does help explain why evolution has not selected against the mechanisms that cause breast milk jaundice. The trait may persist precisely because a mild bilirubin bump confers a small advantage, with the rare extreme case being the evolutionary trade-off.